HighTower Advisors’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $251K | Sell |
7,956
-678
| -8% | -$21.4K | ﹤0.01% | 3074 |
|
|
2025
Q1 | $283K | Sell |
8,634
-496
| -5% | -$16.2K | ﹤0.01% | 2896 |
|
|
2024
Q4 | $330K | Buy |
9,130
+624
| +7% | +$22.6K | ﹤0.01% | 2798 |
|
|
2024
Q3 | $264K | Buy |
+8,506
| New | +$264K | ﹤0.01% | 2900 |
|
|
2024
Q1 | – | Sell |
-13,708
| Closed | -$395K | – | 3515 |
|
|
2023
Q4 | $395K | Buy |
13,708
+1,231
| +10% | +$35.5K | ﹤0.01% | 2482 |
|
|
2023
Q3 | $341K | Buy |
+12,477
| New | +$341K | ﹤0.01% | 2485 |
|
|
2023
Q2 | – | Sell |
-5,962
| Closed | -$221K | – | 3340 |
|
|
2023
Q1 | $221K | Sell |
5,962
-1,270
| -18% | -$47.1K | ﹤0.01% | 2664 |
|
|
2022
Q4 | $263K | Buy |
+7,232
| New | +$263K | ﹤0.01% | 2543 |
|
|
2020
Q3 | – | Sell |
-51,379
| Closed | -$1.22M | – | 2412 |
|
|
2020
Q2 | $1.22M | Buy |
+51,379
| New | +$1.22M | 0.01% | 1026 |
|
|
2018
Q4 | – | Sell |
-4,035
| Closed | -$203K | – | 2226 |
|
|
2018
Q3 | $203K | Sell |
4,035
-190
| -4% | -$9.56K | ﹤0.01% | 1948 |
|
|
2018
Q2 | $252K | Buy |
+4,225
| New | +$252K | ﹤0.01% | 1782 |
|
|
2016
Q4 | – | Sell |
-18,761
| Closed | -$464K | – | 1970 |
|
|
2016
Q3 | $464K | Buy |
+18,761
| New | +$464K | 0.01% | 1276 |
|
|
2016
Q2 | – | Sell |
-20,207
| Closed | -$306K | – | 1933 |
|
|
2016
Q1 | $306K | Sell |
20,207
-1,475
| -7% | -$22.3K | ﹤0.01% | 1526 |
|
|
2015
Q4 | $295K | Buy |
+21,682
| New | +$295K | ﹤0.01% | 1578 |
|